References:

1. Staab CA, Maser E. 11beta-Hydroxysteroid dehydrogenase type 1 is an important regulator at the interface of obesity and inflammation. J Steroid Biochem Mol Biol, 2010 Mar;119(1-2):56-72.

2. London E, Castonguay TW. Diet and the role of 11beta-hydroxysteroid dehydrogenase-1 on obesity. J Nutr Biochem, 2009 Jul;20(7):485-93.

3. Volek JS, Sharman MJ, et al. Body composition and hormonal responses to a carbohydrate-restricted diet. Metabolism, 2002 Jul;51(7):864-70.

4. Morton NM, Seckl JR. 11beta-hydroxysteroid dehydrogenase type 1 and obesity. Front Horm Res, 2008;36:146-64.

5. Tomlinson JW, Sherlock M, et al. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis. J Clin Endocrinol Metab, 2007 Mar;92(3):857-64.

6. Paulsen SK, Pedersen SB, et al. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization. Obesity (Silver Spring), 2007 Aug;15(8):1954-60.

7. Zhu L, Hou M, et al. Testosterone stimulates adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in a depot-specific manner in children. J Clin Endocrinol Metab, 2010 Jul;95(7):3300-8.

8. Desbriere R, Vuaroqueaux V, et al. 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients. Obesity (Silver Spring), 2006 May;14(5):794-8.

9. Engeli S, Böhnke J, et al. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res, 2004 Jan;12(1):9-17.

10. Friedberg M, Zoumakis E, et al. Modulation of 11 beta-hydroxysteroid dehydrogenase type 1 in mature human subcutaneous adipocytes by hypothalamic messengers. J Clin Endocrinol Metab, 2003 Jan;88(1):385-93.

11. Fain JN. Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediators Inflamm, 2010. Epub 2010 May 23.

12. Dovio A, Roveda E, et al. Intense physical exercise increases systemic 11beta-hydroxysteroid dehydrogenase type 1 activity in healthy adult subjects. Eur J Appl Physiol, 2010 Mar;108(4):681-7.

13. Purnell JQ, Kahn SE, et al. Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss. Am J Physiol Endocrinol Metab, 2009 Feb;296(2):E351-7.

14. Lee MJ, Fried SK, et al. Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue. Obesity (Silver Spring), 2008 Jun;16(6):1178-85.

15. Berthiaume M, Laplante M, et al. 11beta-HSD1 inhibition improves triglyceridemia through reduced liver VLDL secretion and partitions lipids toward oxidative tissues. Am J Physiol Endocrinol Metab, 2007 Oct;293(4):E1045-52.

16. Odermatt A, Gumy C, et al. Disruption of glucocorticoid action by environmental chemicals: potential mechanisms and relevance. J Steroid Biochem Mol Biol, 2006 Dec;102(1-5):222-31.

17. Marandici A, Monder C. Inhibition by glycyrrhetinic acid of rat tissue 11 beta-hydroxysteroid dehydrogenase in vivo. Steroids, 1993 Apr;58(4):153-6.

18. Armanini D, Bonanni G, et al. Licorice consumption and serum testosterone in healthy man. Exp Clin Endocrinol Diabetes, 2003 Sep;111(6):341-3.

19. Agha A, Monson JP. Modulation of glucocorticoid metabolism by the growth hormone - IGF-1 axis. Clin Endocrinol (Oxf), 2007 Apr;66(4):459-65.

20. Wake DJ, Stimson RH, et al. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men. J Clin Endocrinol Metab, 2007 May;92(5):1848-56.

21. Asensio C, Muzzin P, et al. Role of glucocorticoids in the physiopathology of excessive fat deposition and insulin resistance. Int J Obes Relat Metab Disord, 2004 Dec;28 Suppl 4:S45-52.